Kymera
meeting summary | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
62 of 63
Similar slides by Kymera
See diffirences between slides (animation)
Investor Presentation
December 2023
overview | Kymera
Investor Presentation
November 2023
overview | Kymera
Investor Presentation
August 2023
what our recent accomplishments mean for and | Kymera
Investor Presentation
August 2023
overview key accomplishments | Kymera
Related slides by other companies
MindMed
Investor Presentation
January 2025
strategies to address key drug class methodological considerations | MindMed
MindMed
Investor Presentation
December 2024
strategies to address key drug class methodological considerations | MindMed
Alkermes
Investor Day
March 2021
evolution to novel drug development with differentiated and contemporary approach employ integrated approach to target selection development and management with continuous evaluation of medical and economic value leverage advanced medicinal chemistry and protein engineering capabilities to develop novel molecular entities with strong intellectual property protection risk programs with front end loaded development plans utilizing forward and reverse translational medicine strategies | Alkermes
MindMed
Investor Presentation
November 2024
strategies to address key drug class methodological considerations | MindMed
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights